Quarterly report pursuant to Section 13 or 15(d)

Business Combinations - Purchase Price Allocation (Details)

v3.21.2
Business Combinations - Purchase Price Allocation (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Apr. 18, 2021
Sep. 30, 2021
Sep. 30, 2021
Statement [Line Items]      
Cash     $ 7,650
Working capital     327
Contingent consideration     750
Total - consideration     8,727
FilAMed      
Statement [Line Items]      
Cash     1,400
Working capital     0
Contingent consideration     0
Total - consideration     1,400
OB Healthcare      
Statement [Line Items]      
Cash $ 6,100 $ 100 6,250
Working capital     327
Contingent consideration     750
Total - consideration     $ 7,327